All endocrine glands are susceptible to neoplastic growth, yet the health consequences of
these neoplasms differ between endocrine tissues. Pituitary neoplasms are highly prevalent …

Prolactinomas and nonfunctioning pituitary adenomas are the most frequent subtypes of
clinically relevant adenomas, followed by acromegaly and Cushing's disease. The incidence …

Substantial advances have been made recently in the pathobiology of pituitary tumors.
Similar to many other endocrine tumors, over the last few years we have recognized the role …

Non-functioning pituitary adenomas, recently alternatively termed pituitary neuroendocrine
tumours (NFpitNETs), are mostly benign neoplasms that are not associated with a hormonal …

The purpose of this study was to analyze the impact of copy number variations (CNV) on
sporadic pituitary neuroendocrine tumors (PitNETs) prognosis, to identify specific prognosis …

No comprehensive classification system that guides prognosis and therapy of pituitary
adenomas exists. The 2022 WHO histopathology-based classification system can only be …

The prevalence of symptomatic pituitary neuroendocrine tumors (PitNETs) is approximately
1 in 1000 in the general population. Most of these tumors occur sporadically and are not part …

Objective Pituitary adenomas (PA) are rare in young patients, and additional studies are
needed to fully understand their pathogenesis in this population. We describe the clinical …

Introduction Pituitary adenomas (PAs) are common, usually benign tumors of the anterior
pituitary gland which, for the most part, have no known genetic cause. PAs are associated …

Simple Summary Pituitary neuroendocrine tumors are non-cancerous tumors of the pituitary
gland, that may overproduce hormones leading to serious health conditions or due to tumor …